January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Rege Nephro Co.,Ltd
Rege Nephro is a clinical-stage biotech company developing small molecule for ADPKD discovered through iPSC-derived human disease models and cell therapy for chronic kidney disease by iPSC-derived nephron progenitor cells